{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:33:22Z","timestamp":1774499602200,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Our objective was to compare norepinephrine plus dobutamine versus epinephrine as the first-line agent in children with fluid refractory cold septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Open-label randomized controlled study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>A single-center PICU from North India.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Children 2 months to less than 18 years old with fluid refractory cold septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>In the intervention group, norepinephrine and dobutamine were started and in the control group, epinephrine was started as the first-line vasoactive agent. The primary outcome was the proportion attaining shock resolution (attaining all the therapeutic endpoints) at 1 hour of therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We enrolled 67 children: 34 in the norepinephrine plus dobutamine group (intervention) and 33 in the epinephrine group (control). There was no difference in shock resolution at 1 hour (17.6% vs 9%; risk ratio [RR], 2.0; 95% CI, 0.54\u20137.35; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.25), 6 hours (76.4% vs 54.5%; RR, 1.69; 95% CI, 0.92\u20133.13; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.06), and 24 hours between the intervention and control groups, respectively. Children in the norepinephrine plus dobutamine group attained shock resolution earlier (measured from starting of vasoactive agents to attaining all the therapeutic endpoints) (hazard ratio, 1.84 [1.1\u20133.08]). The difference in 28-day mortality was not significant (23.5% vs 39.3% in the intervention and control groups, respectively [RR, 0.59; 95% CI, 0.28\u20131.25]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In children with fluid refractory cold septic shock, with use of norepinephrine plus dobutamine as first-line agents, the difference in the proportion of children attaining shock resolution at 1 hour between the groups was inconclusive. However, the time to shock resolution was earlier in the norepinephrine plus dobutamine group. Also, fewer children in the intervention group were refractory to treatment. Further studies powered to detect (or exclude) an important difference would be required to test this intervention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000815","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T14:27:35Z","timestamp":1674743255000},"page":"e0815","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["A Randomized Controlled Trial of Norepinephrine Plus Dobutamine Versus Epinephrine As First-Line Vasoactive Agents in Children With Fluid Refractory Cold Septic Shock"],"prefix":"10.1097","volume":"5","author":[{"given":"Kiran Kumar","family":"Banothu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhuma","family":"Sankar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. Vijaya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Pathak","sequence":"additional","affiliation":[{"name":"Research & Development Department, Kalinga Institute of Medical Sciences, Bhubaneswar, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana Ram","family":"Jat","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil Kumar","family":"Kabra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/CCM.0000000000002425","article-title":"American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock.","volume":"45","author":"Davis","year":"2017","journal-title":"Crit Care Med"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1542\/peds.102.2.e19","article-title":"Hemodynamic support in fluid- refractory pediatric septic shock.","volume":"102","author":"Ceneviva","year":"1998","journal-title":"Pediatrics"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0897190019844124","article-title":"Vasoactive agents for adult septic shock: An update and review.","volume":"33","author":"Dalimonte","year":"2020","journal-title":"J Pharm Pract"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/PCC.0b013e3182a5589c","article-title":"Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: A pilot observational study.","volume":"15","author":"Ranjit","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1542\/peds.2007-1979","article-title":"Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care.","volume":"122","author":"Brierley","year":"2008","journal-title":"Pediatrics"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/adc.77.6.516","article-title":"Clinicians\u2019 abilities to estimate cardiac index in ventilated children and infants.","volume":"77","author":"Tibby","year":"1997","journal-title":"Arch Dis Child"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/PCC.0000000000000249","article-title":"Prevalence and outcome of diastolic dysfunction in children with fluid refractory septic shock--a prospective observational study.","volume":"15","author":"Sankar","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1074248414559838","article-title":"Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.","volume":"20","author":"Jentzer","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial.","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001340050329","article-title":"Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study.","volume":"23","author":"Levy","year":"1997","journal-title":"Intensive Care Med"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.","volume":"39","author":"Levy","year":"2011","journal-title":"Crit Care Med"},{"key":"R13-20240807","first-page":"654","article-title":"Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.","volume":"23","author":"Zhou","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"R14-20240807","first-page":"S876","article-title":"Part 14: Pediatric advanced life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.","volume":"122","author":"Kleinman","year":"2010","journal-title":"Circulation"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2223\/JPED.912","article-title":"Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.","volume":"78","author":"Carcillo","year":"2002","journal-title":"J Pediatr (Rio J)"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200902-0221OC","article-title":"Vasopressin in pediatric vasodilatory shock: A multicenter randomized controlled trial.","volume":"180","author":"Choong","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","article-title":"Vasoactive\u2013inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"e172352","DOI":"10.1001\/jamapediatrics.2017.2352","article-title":"Adaptation and validation of a pediatric Sequential Organ Failure Assessment score and evaluation of the Sepsis-3 definitions in critically ill children.","volume":"171","author":"Matics","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: An update of the PEdiatric logistic organ dysfunction score.","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/tropej\/fmx105","article-title":"Prevalence and outcome of sepsis-induced myocardial dysfunction in children with \u201csepsis\u201d \u201cwith\u201d and \u201cwithout shock\u201d-a prospective observational study.","volume":"64","author":"Jain","year":"2018","journal-title":"J Trop Pediatr"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.medin.2011.01.014","article-title":"[Estimating cardiac output. Utility in the clinical practice. Available invasive and non-invasive monitoring].","volume":"35","author":"Garc\u00eda","year":"2011","journal-title":"Med Intensiva"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1097\/PCC.0000000000000954","article-title":"Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory hypotensive septic shock.","volume":"17","author":"Ramaswamy","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"535","DOI":"10.21037\/atm.2019.09.134","article-title":"Combination era, using combined vasopressors showed benefits in treating septic shock patients: A network meta-analysis of randomized controlled trials.","volume":"7","author":"Chen","year":"2019","journal-title":"Ann Transl Med"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13054-019-2427-4","article-title":"Comparative efficacy of vasoactive medications in patients with septic shock: A network meta-analysis of randomized controlled trials.","volume":"23","author":"Cheng","year":"2019","journal-title":"Crit Care"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:15:29Z","timestamp":1723040129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000815","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]}}}